162 related articles for article (PubMed ID: 25232491)
1. Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters.
Akhter J; Pillai K; Chua TC; Alzarin N; Morris DL
Am J Cancer Res; 2014; 4(5):495-507. PubMed ID: 25232491
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: an
Pillai K; Akhter J; Morris DL
Pleura Peritoneum; 2017 Jun; 2(2):111-117. PubMed ID: 30911639
[TBL] [Abstract][Full Text] [Related]
3. Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP).
Pillai K; Akhter J; Mekkawy A; Chua TC; Morris DL
Int J Med Sci; 2017; 14(1):18-28. PubMed ID: 28138305
[No Abstract] [Full Text] [Related]
4. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
Pillai K; Akhter J; Chua TC; Morris DL
Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
[TBL] [Abstract][Full Text] [Related]
5. Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei.
Pillai K; Akhter J; Chua TC; Morris DL
J Surg Res; 2012 May; 174(2):e69-73. PubMed ID: 22261589
[TBL] [Abstract][Full Text] [Related]
6. Pseudomyxoma peritonei: does a true mucolytic agent exist? In vitro and in vivo studies.
Shyr YM; Su CH; Wang HC; Lo SS; Lui WY
Am Surg; 1995 Mar; 61(3):265-70. PubMed ID: 7887544
[TBL] [Abstract][Full Text] [Related]
7. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.
Ronnett BM; Yan H; Kurman RJ; Shmookler BM; Wu L; Sugarbaker PH
Cancer; 2001 Jul; 92(1):85-91. PubMed ID: 11443613
[TBL] [Abstract][Full Text] [Related]
8. Acidic glycosaminoglycans of abdominal mucin in a case of pseudomyxoma peritonei caused by appendiceal cancer.
Miyashita T; Murata K; Hoshino E; Nishiya H; Ono Y; Akaoka I; Kunii O
Dig Dis Sci; 1999 Nov; 44(11):2231-4. PubMed ID: 10573367
[TBL] [Abstract][Full Text] [Related]
9. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
10. Novel Use of Bromelain and Acetylcysteine (BromAc®) for Pleural Involvement in Pseudomyxoma Peritonei.
Lam AR; Bazzi K; Valle SJ; Morris DL
Case Rep Oncol; 2021; 14(1):628-633. PubMed ID: 33976645
[TBL] [Abstract][Full Text] [Related]
11. Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei.
Romero-Ruiz A; Granados-Rodríguez M; Bura FI; Valenzuela-Molina F; Rufián-Andújar B; Martínez-López A; Rodríguez-Ortiz L; Ortega-Salas R; Torres-Martínez M; Moreno-Serrano A; Castaño J; Michán C; Alhama J; Vázquez-Borrego MC; Arjona-Sánchez Á
Biol Proced Online; 2024 May; 26(1):13. PubMed ID: 38750435
[TBL] [Abstract][Full Text] [Related]
12. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei.
Ronnett BM; Seidman JD
Am J Surg Pathol; 2003 May; 27(5):650-7. PubMed ID: 12717249
[TBL] [Abstract][Full Text] [Related]
13. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.
O'Connell JT; Tomlinson JS; Roberts AA; McGonigle KF; Barsky SH
Am J Pathol; 2002 Aug; 161(2):551-64. PubMed ID: 12163380
[TBL] [Abstract][Full Text] [Related]
14. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".
Ronnett BM; Zahn CM; Kurman RJ; Kass ME; Sugarbaker PH; Shmookler BM
Am J Surg Pathol; 1995 Dec; 19(12):1390-408. PubMed ID: 7503361
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
[TBL] [Abstract][Full Text] [Related]
16. MUC2 is a molecular marker for pseudomyxoma peritonei.
O'Connell JT; Hacker CM; Barsky SH
Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series.
Valenzuela-Molina F; Bura FI; Vázquez-Borrego MC; Granados-Rodríguez M; Rufián-Andujar B; Rufián-Peña S; Casado-Adam Á; Sánchez-Hidalgo JM; Rodríguez-Ortiz L; Ortega-Salas R; Martínez-López A; Michán C; Alhama J; Arjona-Sánchez Á; Romero-Ruiz A
Front Oncol; 2023; 13():1076500. PubMed ID: 36776312
[TBL] [Abstract][Full Text] [Related]
18. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.
Carr NJ; Cecil TD; Mohamed F; Sobin LH; Sugarbaker PH; González-Moreno S; Taflampas P; Chapman S; Moran BJ;
Am J Surg Pathol; 2016 Jan; 40(1):14-26. PubMed ID: 26492181
[TBL] [Abstract][Full Text] [Related]
19. In vivo model of pseudomyxoma peritonei for novel candidate drug discovery.
Chua TC; Akther J; Yao P; Morris DL
Anticancer Res; 2009 Oct; 29(10):4051-5. PubMed ID: 19846950
[TBL] [Abstract][Full Text] [Related]
20. Significance of epithelial cell clusters in pseudomyxoma peritonei.
Badyal RK; Khairwa A; Rajwanshi A; Nijhawan R; Radhika S; Gupta N; Dey P
Cytopathology; 2016 Dec; 27(6):418-426. PubMed ID: 27121698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
